The Next Phase of Price Transparency: Why Medicare Advantage Should Be the Focus
Medicare Advantage (MA) already offers substantially greater price predictability than traditional Medicare — MA enrollees saw monthly out-of-pocket costs 18–24% lower than traditional Medicare from 2014 to 2019, and MA plans include annual out-of-pocket caps that fee-for-service lacks entirely. Authors Chandrashekar and Jain argue that price transparency policy has been misdirected toward traditional Medicare, and the real opportunity lies in operationalizing existing MA infrastructure. Their roadmap targets three levers: AI-assisted plan selection tools that use prior claims data to generate personalized annual cost estimates, passive in-workflow displays that steer clinicians toward lower-cost referral and ordering decisions without adding administrative burden, and MA star ratings reform to financially incentivize plans to build transparency tools. The next phase of price transparency isn’t building it from scratch — it’s deploying what already exists within MA.
For multi-site operators, price is both a growth lever and a friction point — MA’s complexity makes true “apples to apples” comparison hard for patients. Practices that communicate pricing clearly, position for lower-cost site-of-care decisions, and align with plan referral networks will win patient acquisition as this transparency infrastructure matures across MA.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.
Why hasn’t federal price transparency policy reduced healthcare costs for Medicare patients?
Federal transparency mandates targeted traditional Medicare’s fee-for-service market, which was never designed for cost predictability. Beneficiaries face layered facility fees and unpredictable coinsurance with no annual out-of-pocket cap — unlike Medicare Advantage, which already delivers 18–24% lower monthly out-of-pocket costs and preset co-payments for routine services like primary care visits, imaging, and specialist referrals.
How can AI tools help Medicare beneficiaries choose lower-cost MA plans?
AI-assisted plan selection tools can use prior claims data, medication lists, and condition-specific utilization patterns to generate personalized annual spending estimates across MA plans — including projected co-payments, drug costs, and worst-case spending exposure. This moves meaningful price comparison upstream to enrollment, where patients actually weigh cost tradeoffs, rather than at the point of care where urgency overrides financial reasoning.
How should healthcare operators embed cost transparency into clinical workflows?
Cost information should surface passively within existing EHR workflows — automatically displaying, for example, when a freestanding imaging center costs significantly less than a hospital outpatient department for the same MRI. Tools that require clinicians to actively search for pricing are unlikely to succeed given existing administrative burden; passive, default-visible cost displays are the only realistic path to changing ordering and referral behavior at scale.